Back to today’s briefing

Story perspectives

Saudi Diabetes Drug Market Set to Double by 2033

8/23/2025

37 3

Summary

Story summary

The Saudi Arabia diabetes drug market is transitioning to advanced therapies, expected to rise from $773.6 million in 2024 to $1.33 billion by 2033.
Growth is fueled by rising diabetes rates, government healthcare investments, and increased awareness.
High costs of new medications pose access challenges for uninsured patients.
Government initiatives under Vision 2030 aim to enhance healthcare access and diabetes management.

1 of 1

Story summary

The Saudi Arabia diabetes drug market is transitioning to advanced therapies, expected to rise from $773.6 million in 2024 to $1.33 billion by 2033.
Growth is fueled by rising diabetes rates, government healthcare investments, and increased awareness.
High costs of new medications pose access challenges for uninsured patients.
Government initiatives under Vision 2030 aim to enhance healthcare access and diabetes management.